Breaking News Instant updates and real-time market news.

KIN

Kindred Biosciences

$10.75

-0.16 (-1.47%)

09:15
03/07/19
03/07
09:15
03/07/19
09:15

Kindred Biosciences price target lowered to $12 from $30 at Lake Street

Lake Street analyst Brooks O'Neil lowered his price target for Kindred Biosciences to $12 following the company's Q4 results while affirming a Buy rating on the shares. The analyst says that while Mirataz, Kindred's first approved drug, is off to a solid start, he now believes revenue from the drug will be lower than modeled previously. However, the company has a "deep pipeline of attractive drug candidates for the large and growing companion animal medicines space," O'Neil tells investors in a research note.

  • 12

    Mar

KIN Kindred Biosciences
$10.75

-0.16 (-1.47%)

08/13/18
HCWC
08/13/18
NO CHANGE
Target $16
HCWC
Buy
Kindred Biosciences price target raised to $16 from $12 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Kindred Biosciences to $16 saying the Mirataz launch is off to a good start. The analyst continues to project Mirataz revenue to reach $1.3M by the end of 2018, growing to $68M by 2027. He reiterates a Buy rating on Kindred following last week's Q2 results.
10/31/18
CANT
10/31/18
NO CHANGE
Target $25
CANT
Overweight
Kindred Biosciences price target raised to $25 from $20 at Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes raised his price target for Kindred Biosciences to $25 citing the positive top-line results from the company's pilot effectiveness study of KIND-016. The analyst now has increased conviction about Kindred's antibody pipeline, which includes KIND-016, a fully caninized, high-affinity IL-31 monoclonal antibody for the treatment of atopic dermatitis in dogs, an IL4/IL13 product that is likely to readout in early 2019, and a number of undisclosed antibody products. He reiterates an Overweight rating on the shares.
11/08/18
HCWC
11/08/18
NO CHANGE
Target $19
HCWC
Buy
Kindred Biosciences price target raised to $19 from $16 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Kindred Biosciences to $19 following the company's Q3 results. The analyst sees a "strong start" for Mirataz and highlights the recent success of KIND-016 for the treatment of canine atopic dermatitis. He reiterates a Buy rating on the shares.
12/03/18
CANT
12/03/18
NO CHANGE
Target $25
CANT
Overweight
Kindred shares remain 'significantly undervalued,' says Cantor Fitzgerald
After hosting meetings with management, Cantor Fitzgerald analyst Brandon Folkes reiterates an Overweight rating on Kindred Biosciences with a $25 price target. Kindred's pipeline of novel animal health drugs will drive long-term shareholder value beyond levels currently reflected in the stock price, Folkes tells investors in a research note. He believes that the company advances its pipeline, investors should begin to appreciate the durability and peak revenue potential of the products the company brings to market. Kindred shares remain "significantly undervalued at current levels," says Folkes.

TODAY'S FREE FLY STORIES

AMRN

Amarin

$18.77

-0.24 (-1.26%)

16:19
03/21/19
03/21
16:19
03/21/19
16:19
Initiation
Amarin initiated  »

Amarin initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

NNDM

Nano Dimension

$0.77

0.012 (1.59%)

16:19
03/21/19
03/21
16:19
03/21/19
16:19
Hot Stocks
Nano Dimension receives Nasdaq non-compliance notification »

Nano Dimension announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RC

Ready Capital

$14.79

0.02 (0.14%)

, ORM

Owens Realty Mortgage

$21.03

(0.00%)

16:19
03/21/19
03/21
16:19
03/21/19
16:19
Hot Stocks
Ready Capital stockholders approve issuance of common stock in Owens merger »

Ready Capital's (RC)…

RC

Ready Capital

$14.79

0.02 (0.14%)

ORM

Owens Realty Mortgage

$21.03

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

CHRW

C.H. Robinson

$87.20

0.58 (0.67%)

16:19
03/21/19
03/21
16:19
03/21/19
16:19
Hot Stocks
C.H. Robinson CFO Andrew Clarke to leave position »

C.H. Robinson announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLNG

Dynagas LNG

$2.61

0.025 (0.97%)

16:19
03/21/19
03/21
16:19
03/21/19
16:19
Earnings
Dynagas LNG reports Q4 EPS (4c), consensus 4c »

Reports Q4 revenue $31M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

CTAS

Cintas

$208.00

2.78 (1.35%)

16:18
03/21/19
03/21
16:18
03/21/19
16:18
Earnings
Cintas raises FY19 EPS view to $7.42-$7.48 from $7.30-$7.38, consensus $7.34 »

Narrows FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

NKE

Nike

$88.05

1.3597 (1.57%)

16:18
03/21/19
03/21
16:18
03/21/19
16:18
Hot Stocks
Nike CFO: Consumer Direct Offense delivering broad-based growth »

"The Consumer Direct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

NKE

Nike

$88.05

1.3597 (1.57%)

16:18
03/21/19
03/21
16:18
03/21/19
16:18
Hot Stocks
Nike reports Q3 North America revenue $3.81B, up 7% »

Reports Q3 EMEA revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

WMC

Western Asset Mortgage

$10.55

0.035 (0.33%)

16:17
03/21/19
03/21
16:17
03/21/19
16:17
Hot Stocks
Western Asset Mortgage estimated book value per share $10.73 as of Feb. 28 »

The February 28 estimated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISNS

Image Sensing Systems

$5.25

(0.00%)

16:17
03/21/19
03/21
16:17
03/21/19
16:17
Hot Stocks
Image Sensing Systems interim CFO Todd Slawson resigns »

Image Sensing Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
03/21/19
03/21
16:17
03/21/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$88.05

1.3597 (1.57%)

16:17
03/21/19
03/21
16:17
03/21/19
16:17
Hot Stocks
Nike reports Q3 Nike Brand revenue $9.15B »

Revenues for the NIKE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

CTAS

Cintas

$208.00

2.78 (1.35%)

16:16
03/21/19
03/21
16:16
03/21/19
16:16
Earnings
Cintas reports Q3 adjusted EPS $1.84, consensus $1.71 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

16:16
03/21/19
03/21
16:16
03/21/19
16:16
Conference/Events
Wolfe Research transport analyst to hold a luncheon »

Transport Analyst Group…

OSS

One Stop Systems

$2.52

(0.00%)

16:16
03/21/19
03/21
16:16
03/21/19
16:16
Earnings
Breaking Earnings news story on One Stop Systems »

One Stop Systems backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

NKE

Nike

$88.05

1.3597 (1.57%)

16:16
03/21/19
03/21
16:16
03/21/19
16:16
Hot Stocks
Nike reports Q3 gross margin 45.1% »

Gross margin increased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

CNI

Canadian National

$87.67

0.74 (0.85%)

16:16
03/21/19
03/21
16:16
03/21/19
16:16
Hot Stocks
Canadian National investing approximately $370M in Alberta rail infrastructure »

CN said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
03/21/19
03/21
16:16
03/21/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$88.05

1.3597 (1.57%)

16:15
03/21/19
03/21
16:15
03/21/19
16:15
Earnings
Nike reports Q3 EPS 68c, consensus 65c »

Reports Q3 revenue $9.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

OSS

One Stop Systems

$2.52

(0.00%)

16:15
03/21/19
03/21
16:15
03/21/19
16:15
Earnings
Breaking Earnings news story on One Stop Systems »

One Stop Systems sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

ZUO

Zuora

$24.34

0.62 (2.61%)

16:15
03/21/19
03/21
16:15
03/21/19
16:15
Hot Stocks
Breaking Hot Stocks news story on Zuora »

Zuora ACV customers over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 23

    Apr

OPNT

Opiant Pharmaceuticals

$14.00

0.5 (3.70%)

16:15
03/21/19
03/21
16:15
03/21/19
16:15
Earnings
Opiant Pharmaceuticals CEO, CFO comment on quarter »

"The opioid epidemic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

16:15
03/21/19
03/21
16:15
03/21/19
16:15
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

16:15
03/21/19
03/21
16:15
03/21/19
16:15
General news
Breaking General news story  »

Week of 3/11 Money Supply…

16:15
03/21/19
03/21
16:15
03/21/19
16:15
General news
Breaking General news story  »

Week of 3/20 Fed Balance…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.